SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is a major trending topic, propelled by recent speculation around a significant supply deficit, surging industrial demand from AI and green energy, and China's upcoming export restrictions from early next year. The community is actively discussing a potential historic short squeeze, with many anticipating continued parabolic price action, while some traders are hedging against a possible short-term pullback in this intensely watched commodity.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending due to its extremely low public float and exceptionally high short borrow rates, fueling intense short squeeze speculation. Community discussion is highly polarized between those anticipating significant upside driven by its "rocket fuel" potential in the active space sector and others warning of a pump-and-dump given its developing business operations. Traders are actively navigating its high volatility, watching for critical price movements amid these conflicting narratives.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

Universe Pharmaceuticals (UPC) is currently trending amidst intense speculation of a short squeeze, driven by its exceptionally low share float. The community is actively debating ambitious price targets, drawing comparisons to other highly volatile micro-cap runners, while some express caution regarding potential manipulation often associated with Chinese pump-and-dump scenarios. Despite these divided opinions, many bulls are highlighting the company's strong cash position and perceived undervaluation as key drivers for a continued rally.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending following positive preliminary analysis from its FLAMINGO-01 trial, reporting an 80% reduction in breast cancer recurrence rates in the open-label arm. This has ignited intense community discussion about a potential short squeeze, driven by significant short interest, high cost to borrow, and consistent insider buying, with many anticipating a major pharmaceutical partnership or buyout.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver (AG) is a hot topic as silver prices surge to new highs, with some observers noting spot prices above $77 in Shanghai. Despite widespread community frustration over the stock's lagging performance relative to the metal, many anticipate an imminent "catch-up" rally. This sentiment is fueled by a perceived structural silver deficit, increasing industrial demand, and the belief that current price action reflects manipulation that cannot sustain against strong market fundamentals.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is a trending topic following a major contract win from the Space Development Agency, which significantly boosts its backlog and solidifies its role as a defense prime. This has ignited strong bullish sentiment within the community, with many anticipating continued upside, while others point to potential overvaluation and recent insider sales as reasons for caution. The company's expanding space systems capabilities and the broader sector's momentum are key discussion points among investors.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

Alpha Capital Acquisition Co. (ASPC) is seeing a surge in trading activity and extreme price volatility, primarily driven by its notably low public float. The community is heavily discussing its short squeeze potential, likening it to other recent low-float SPAC runners, while also noting its history of rapid pumps and dumps and frequent trading halts. This intense market action appears largely technical, fueled by supply constraints and significant short interest rather than any specific fundamental news.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is gaining significant market attention driven by its recent Marigold acquisition and upcoming showcase at CES, where its AI-powered Athena platform is a key focus. The community largely believes ZETA remains undervalued, anticipating a major upward re-rating and a powerful surge as it demonstrates consistent execution and leverage in AI-driven marketing technology.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending following China's sanctions and recent U.S. regulatory actions against foreign-made drones, which the community widely interprets as a strong bullish signal for its strategic defense role. Investors are anticipating significant contract awards for its Black Widow drones and Blue Ops unmanned surface vessels, fueled by increasing defense budgets and the company's expanding domestic production capacity.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is experiencing a significant rally following reports of a substantial investment by TOMS Capital Investment Management, igniting widespread community buzz and driving notable upward price action. This strong momentum, highlighted by a series of green days and bullish sentiment, is further supported by broader positive retail sector trends and improving shrink reduction efforts, fueling speculation for a sustained comeback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RLYB  
Bought 50k more share this a.m.  Still believe data likely to be before Tue of next week.... 
 
Data pushing to the last minute could be because of what I said below, or it could be from a strategic deal coming like an acquisition/partner/RM.  Either way, cash is still sitting at $1.50/share so seems like a safe downside risk play no matter what imo.  And the fact that all of the original VCs are still holding their mega bag positions points that an exit liquidity event is likely coming soon.  Buying more daily :)

Giuseppe

Evan Nash

Ted Kramer

$RLYB Someone help me do some math here.  If Cohort 2 started after the Sept 25 PR and it&#39;s a 4 week treatment period followed by a 10 week follow-up (14 week total).  How would they be able to release data by Q4 ? Hoping news this or next week but wouldn&#39;t be surprised if it spilled over to first or second week in Q1 2026.   
 
References: 
Sept 25, 2025 PR: 
&quot;Sept 2025 was completion of dosing from Cohort 1 and &quot;Data from Cohort 1 support the advancement of RLYB116 as a differentiated therapeutic and enables progression to Cohort 2. Rallybio is on track to report data from the study in the fourth quarter of 2025.&quot; 
 
&quot;The study is evaluating a 4-week treatment duration that includes two cohorts of eight participants each, randomized 3 to 1 to receive either RLYB116 or placebo once weekly. Cohort 1 evaluated dosing of 150 mg and Cohort 2 will evaluate dosing of up to 300 mg. The study includes a 10-week follow-up period after the conclusion of treatment.&quot;

StockTwits Web

Rallybio Corp

  
Bought 50k more share this a.m.  Still believe data likely to be before Tue of next week.... 
 
Data pushing to the last minute could be because of what I said below, or it could be from a strategic deal coming like an acquisition/partner/RM.  Either way, cash is still sitting at $1.50/share so seems like a safe downside risk play no matter what imo.  And the fact that all of the original VCs are still holding their mega bag positions points that an exit liquidity event is likely coming soon.  Buying more daily :)

@skyrockets_Inc If there is a slight delay it&#39;s either due to when the last patient was enrolled or biz development (or both). Looks like last patient enrolled mid-November. Four-week study + lab turnover time puts us right around now. I prefer they wait until early January actually at this point.

 If there is a slight delay it's either due to when the last patient was enrolled or biz development (or both). Looks like last patient enrolled mid-November. Four-week study + lab turnover time puts us right around now. I prefer they wait until early January actually at this point.

Brian Thomson

@SDBiotechInvestor exactly why i posted my original question above.  timeline always seemed tight to me so pushing into Q1 doens&#39;t seem like a huge deal to me.

 exactly why i posted my original question above.  timeline always seemed tight to me so pushing into Q1 doens't seem like a huge deal to me.